The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
Open accessAbstract
Some EBV+ BL cell lines continue to grow as single cells on in vitro passage, show an unusually restricted expression of EBV-latent genes and retain a BL biopsy-like cell surface phenotype (group I/II lines); others change to growth in aggregates, show a broader pattern of virus latent gene expression, and develop a cell surface phenotype more characteristic of EBV-transformed LCL (group III lines). Here we show that the cell surface adhesion molecules LFA-1, ICAM-1, and LFA-3 are expressed at very low levels, if at all, on group I/II lines and are coordinately upregulated as BL lines move towards group III. The change to growth in aggregates reflects the increasing availability of LFA-1 and ICAM-1, the two ligands whose mutual interaction underlies homotypic BL cell adhesion in vitro. The low levels of ICAM-1 and LFA-3 on group I/II BL cell lines are also associated with an impaired ability to interact with EBV-specific CTL in the antigen-independent phase of effector/target conjugation. mAb blocking studies show that the small number of conjugates that are formed with group I/II BL targets involve the LFA-1/ICAM-1 adhesion pathway but not the LFA-3 pathway; in contrast, both pathways contribute to the efficient conjugate formation shown by group III BL or LCL targets. Earlier work identified one group III line, WW1 BL, as unusual since is expressed the full spectrum of EBV-latent proteins yet remained insensitive to lysis by EBV-specific CTL. Here we show that this line has an anomalous pattern of adhesion molecule expression with high levels of LFA-1 and ICAM-1 in the absence of detectable LFA-3. The WW1 BL cells form conjugates with EBV-specific CTL through the LFA-1/ICAM-1 pathway, but in the absence of a target LFA-3/effector CD2 interaction these conjugates do not achieve target cell lysis. This may reflect an important role for target LFA-3 molecules in activating EBV-specific CTL function. From these in vitro studies, we postulate that downregulation of the adhesion molecules LFA-3 and ICAM-1 on EBV+ BL underlies the ability of the malignant clone to evade EBV-specific T cell surveillance in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barnstable, C. (1978) · Cell · doi:10.1016/0092-8674(78)90296-9 · Cited by 1,916
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.
Rothlein, R., Dustin, M. L., Marlin, S. D., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1270 · Cited by 1,400
LEUKOCYTE ADHESION DEFICIENCY: An Inherited Defect in the Mac-1, LFA-1, and p150,95 Glycoproteins
Anderson, D. C., & Springer, T. A. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.001135 · Cited by 1,148
Meuer, S. C., Hussey, R. E., Fabbi, M., Fox, D., Acuto, O., Fitzgerald, K. A., Hodgdon, J. C., Protentis, J. P., Schlossman, S. F., & Reinherz, E. L. (1984) · Cell · doi:10.1016/0092-8674(84)90039-4 · Cited by 1,113
Springer, T. (1987) · Annual Review of Immunology · doi:10.1146/annurev.immunol.5.1.223 · Cited by 1,110
Sanchez-Madrid, F., Nagy, J. A., Robbins, E., Simon, P., & Springer, T. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.6.1785 · Cited by 873
Sanchez-Madrid, F., Krensky, A. M., Ware, C. F., Robbins, E., Strominger, J. L., Burakoff, S. J., & Springer, T. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.23.7489 · Cited by 718
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
Self-citationRothlein, R., & Springer, T. A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1132 · Cited by 474
Pope, J. H., Horne, M. K., & Scott, W. M. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030619 · Cited by 472
Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones
Shaw, S., Ginther Luce, G. E., Quinones, R., Gress, R. E., Springer, T. A., & Sanders, M. E. (1986) · Nature · doi:10.1038/323262a0 · Cited by 426
Makgoba, M. W., Sanders, M. E., Luce, G. E. G., Gugel, E. A., Dustin, M. L., Springer, T. A., & Shaw, S. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180423 · Cited by 313
A human lymphocyte‐associated antigen involved in cell‐mediated lympholysis
Hildreth, J. E. K., Gotch, F. M., Hildreth, P. D. K., & McMichael, A. J. (1983) · European Journal of Immunology · doi:10.1002/eji.1830130305 · Cited by 305
Rowe, D. T., Rowe, M., Evan, G. I., Wallace, L. E., Farrell, P. J., & Rickinson, A. B. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04540.x · Cited by 196
Self-citationABSENCE OF CELL SURFACE LFA-1 AS A MECHANISM OF ESCAPE FROM IMMUNOSURVEILLANCE
Clayberger, C., Medeiros, L. J., Link, M., Warnke, R., Wright, A. M., Koller, T. D., Smith, S., & Krensky, A. M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92924-2 · Cited by 126
Shaw, S., & Luce, G. E. G. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.4.1037 · Cited by 111
Rooney, C. M., Gregory, C. D., Rowe, M., Finerty, S., Edwards, C., Rupani, H., & Rickinson, A. B. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.3.681 · Cited by 107
Self-citationMurray, R. J., Young, L. S., Calender, A., Gregory, C. D., Rowe, M., Lenoir, G., & Rickinson, A. B. (1988) · Journal of Virology · doi:10.1128/jvi.62.3.894-901.1988 · Cited by 82
Self-citation
Cited by
Mycophenolate mofetil and its mechanisms of action
Allison, A. C., & Eugui, E. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00188-0 · Cited by 1,433
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Self-citationIntercellular adhesion molecule-1
van de Stolpe, A., & van der Saag, P. T. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202069 · Cited by 802
Young, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211604 · Cited by 749
Self-citationHUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
Self-citation
Metadata
- Authors
- Gregory, C. D., Murray, R. J., Edwards, C. F., & Rickinson, A. B.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1988-06-01
- Volume
- 167
- Issue
- 6
- Pages
- 1811-1824
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1973061854
- Cited by
- 329
- References
- 18
- FWCI
- 16.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.